The global demand for Radiation Dermatitis Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Radiation dermatitis, radiodermatitis, or x-ray dermatitis is skin damage or a radiation burn caused by external beam ionizing radiation of radiotherapy for cancer tumors. It may also rarely result from exposure to radiation during interventional procedures such as embolization procedures, coronary angiography, and indwelling catheter placements. Radiation dermatitis is primarily treated with topical agents such as corticosteroids, topical antibiotics, hydrophilic creams, oral medications like oral corticosteroids, oral analgesics, anti-inflammatory agents, antibiotics, and dressings.
Market Dynamics
A rising number of procedures, including radiotherapy, embolization procedures, coronary angiography, and indwelling catheter placements, are responsible for increasing radiation dermatitis prevalence. The escalating burden of cancer and advances in radiation delivery technology, such as intensity-modulated radiation therapy, is driving the global radiation dermatitis market. Radiotherapy is majorly contributing to the rising radiation dermatitis incidences. Radiation therapy remains an essential component of cancer treatment, with nearly 50% of cancer patients receiving radiation therapy at some point during their treatment. Rising effort towards reducing side effects associated with radiation therapy is expected to offer lucrative opportunities for the market expansion during the forecast timeframe. However, lack of awareness and the high cost associated with radio dermatitis treatment is anticipated to restrict the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of radiation dermatitis. The growth and trends of radiation dermatitis industry provide a holistic approach to this study.
Market Segmentation
This section of the radiation dermatitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Topical
- Corticosteroids
- Hydrophilic Creams
- Topical Antibiotics
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Radiation Dermatitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Radiation Dermatitis Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the radiation dermatitis market include 3M Company, Bausch Health Companies Inc, Bayer Ag, BMG Pharma SPA, Convatec Group Plc, Glaxosmithkline Plc, Helsinn Healthcare SA, Molnlycke Health Care, Mylan N.V., Smith & Nephew Plc, and Stratpharma Ag.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.